Deciphera Pharmaceuticals, Inc. Banner Image

Deciphera Pharmaceuticals, Inc.

  • Ticker DCPH
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Deciphera Pharmaceuticals, Inc. Logo Image
  • 201-500 Employees
  • Based in Waltham, Massachusetts
Deciphera is a biopharmaceutical company focused on discovering, developing and commercializing important new medicines to improve the lives of people with cancer. They are leveraging their proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. In addition to advancing multiple product candidates fromMore their platform in clinical studies, QINLOCKTM is Deciphera’s FDA-approved switch-control kinase inhibitor for the treatment of fourth-line gastrointestinal stromal tumor (GIST). QINLOCK is also approved for fourth-line GIST in Canada and Australia.
4.8 / 5.0 (172)

Deciphera Pharmaceuticals, Inc. reports have an aggregate usefulness score of 4.8 based on 172 reviews.

Deciphera Pharmaceuticals, Inc.

Most Recent Annual Report

Deciphera Pharmaceuticals, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Deciphera Pharmaceuticals, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!